Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
retina
Biotech
Atsena downsizes to funnel money toward new capsid program
Atsena Therapeutics has cut staff to funnel more money toward an inherited retinal disease program that just began in August.
Max Bayer
Oct 5, 2023 1:47pm
Zeiss, Boehringer eye retinal disease-focused predictive AI pact
Oct 2, 2023 1:00pm
Cash-strapped eye disease biotech halves portfolio
Aug 8, 2023 2:36pm
Vedere Bio II, unimpressed by preclinical work, shuts down
Apr 3, 2023 10:35am
Quick retina scans may be AI's key to predicting heart disease
Oct 7, 2022 11:41am
